The Patent Finder

Gemphire Therapeutics Inc.

Also on record
Records under this name other than patents Gemphire Therapeutics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Gemphire Therapeutics Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,846,761Method for Treating Pancreatitis
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,709,678Methods of Reducing Risk of Cardiovascular Disease
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,227,285Processes and Intermediates for Preparing Alpha,omega -Dicarboxylic Acid-Terminated Dialkane Ethers
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,849,104Treatment of NASH with Gemcabene
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,449,154Treatment of NASH with Gemcabene
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,028,926Methods of Reducing Risk of Cardiovascular Disease
Formerly held
Lapsed on the fee record
Ended Jul 24, 2022 · High confidence
Lapsed on the fee recordEnded Jul 24, 2022High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited